At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 14 enrolled
Drug / intervention
CT angiographyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation Study of Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning
University of Texas Southwestern Medical Center·interventional·Posted Jun 18, 2018·Updated Oct 15, 2024
In Brief
A Early Phase 1 clinical trial evaluating CT angiography for Arteriovenous Malformations. Completed, enrolled 14 participants across 1 site.
Detailed Summary
Evaluate whether a treatment plan based on CT angiography can accurately and precisely identify the target nidus as compared to standard cerebral arteriography fused to MRI.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArteriovenous Malformations
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
20192020202120222023202420252026
First PostedJun 2018
Enrollment StartJul 2019
Primary CompletionSep 2021
Study CompletionJun 2024
TodayJul 2026
First PostedJun 18, 2018
Enrollment StartJul 25, 2019
Primary CompletionSep 10, 2021
Study CompletionJun 24, 2024
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 8.0 years ago
Interventions
CT angiographyother
CT angiography uses a CT scanner to produce detailed images of both blood vessels and tissues in various parts of the body. An iodine-rich contrast material (dye) is usually injected through a small catheter placed in a vein of the arm.